| 1. |
Klein MD (2006) Congenital defects of the abdominal wall. In: Grosfeld JL, O’Neill JA, Coran AG, Fonkalsrud EW (eds) Pediatric
surgery. Elsevier, Philadelphia, pp 1157–1171
|
| |
| 2. |
Drewett M, Michailidis GD, Burge D (2006) The perinatal management of gastroschisis. Early Hum Dev 82:305–312
|
| |
| 3. |
Snyder CL (1999) Outcome analysis for gastroschisis. J Pediatr Surg 34:1253–1256
|
| |
| 4. |
Axt R, Quijano F, Boos R, Hendrik HJ, Jessberger HJ, Schwaiger C, Schmidt W (1999) Omphalocele and gastroschisis: prenatal
diagnosis and peripartal management. A case analysis of the years 1989–1997 at the Department of Obstetrics and Gynecology,
University of Homburg/Saar. Eur J Obstet Gynecol Reprod Biol 87:47–54
|
| |
| 5. |
Hunter AG, Stevenson RE (2008) Gastroschisis: clinical presentation and associations. Am J Med Genet C Semin Med Genet 148C:219–230
|
| |
| 6. |
Mastroiacovo P, Lisi A, Castilla EE, Martinez-Frias ML, Bermejo E, Marengo L, Kucik J, Siffel C, Halliday J, Gatt M, Anneren
G, Bianchi F, Canessa MA, Danderfer R, de Walle H, Harris J, Li Z, Lowry RB, McDonell R, Merlob P, Metneki J, Mutchinick O,
Robert-Gnansia E, Scarano G, Sipek A, Potzsch S, Szabova E, Yevtushok L (2007) Gastroschisis and associated defects: an international
study. Am J Med Genet A 143:660–671
|
| |
| 7. |
NBDPN (2007) Population-based birth defects surveillance data from selected states, 2000–2004. Birth Defects Res A Clin Mol
Teratol 79:874–942
|
| |
| 8. |
Hwang PJ, Kousseff BG (2004) Omphalocele and gastroschisis: an 18-year review study. Genet Med 6:232–236
|
| |
| 9. |
Stoll C, Alembik Y, Dott B, Roth MP (2001) Risk factors in congenital abdominal wall defects (omphalocele and gastroschisi):
a study in a series of 265, 858 consecutive births. Ann Genet 44:201–208
|
| |
| 10. |
Stoll C, Alembik Y, Dott B, Roth MP (2008) Omphalocele and gastroschisis and associated malformations. Am J Med Genet A 146A:1280–1285
|
| |
| 11. |
Rankin J, Dillon E, Wright C (1999) Congenital anterior abdominal wall defects in the north of England, 1986–1996: occurrence
and outcome. Prenat Diagn 19:662–668
|
| |
| 12. |
Boyd PA, Bhattacharjee A, Gould S, Manning N, Chamberlain P (1998) Outcome of prenatally diagnosed anterior abdominal wall
defects. Arch Dis Child Fetal Neonatal Ed 78:F209–F213
|
| |
| 13. |
Calzolari E, Volpato S, Bianchi F, Cianciulli D, Tenconi R, Clementi M, Calabro A, Lungarotti S, Mastroiacovo PP, Botto L
et al (1993) Omphalocele and gastroschisis: a collaborative study of five Italian congenital malformation registries. Teratology
47:47–55
|
| |
| 14. |
Lindham S (1981) Omphalocele and gastroschisis in Sweden 1965–1976. Acta Paediatr Scand 70:55–60
|
| |
| 15. |
Kazaura MR, Lie RT, Irgens LM, Didriksen A, Kapstad M, Egenaes J, Bjerkedal T (2004) Increasing risk of gastroschisis in Norway:
an age-period-cohort analysis. Am J Epidemiol 159:358–363
|
| |
| 16. |
Di Tanna GL, Rosano A, Mastroiacovo P (2002) Prevalence of gastroschisis at birth: retrospective study. BMJ 325:1389–1390
|
| |
| 17. |
Suita S, Okamatsu T, Yamamoto T, Handa N, Nirasawa Y, Watanabe Y, Yanagihara J, Nishijima E, Hirobe S, Nio M, Gomi A, Horisawa
M (2000) Changing profile of abdominal wall defects in Japan: results of a national survey. J Pediatr Surg 35:66–71 (discussion
72)
|
| |
| 18. |
Benson CD, Penberthy GC, Hill EJ (1949) Hernia into umbilical cord and omphalocele. Arch Surg 58:833–847
|
| |
| 19. |
Moore TC, Stokes GE (1953) Gastroschisis; report of two cases treated by a modification of the gross operation for omphalocele.
Surgery 33:112–120
|
| |
| 20. |
http://www.who.int/classifications/apps/icd/icd10online/
|
| |
| 21. |
Padmanabhan R, al-Zuhair AG (1987) Congenital malformations and intrauterine growth retardation in streptozotocin induced
diabetes during gestation in the rat. Reprod Toxicol 1:117–125
|
| |
| 22. |
Samarawickrama GP, Webb M (1981) The acute toxicity and teratogenicity of cadmium in the pregnant rat. J Appl Toxicol 1:264–269
|
| |
| 23. |
Beauchemin RR Jr, Gartner LP, Provenza DV (1984) Alcohol induced cardiac malformations in the rat. Anat Anz 155:17–28
|
| |
| 24. |
Fisher CJ, Sawyer RH (1980) The effect of triamcinolone on the development of the bursa of fabricius in chick embryos. Teratology
22:7–12
|
| |
| 25. |
Gutova M, Elis J, Raskova H (1971) Teratogenic effect of 6-azauridine in rats. Teratology 4:287–294
|
| |
| 26. |
Padmanabhan R (1998) Retinoic acid-induced caudal regression syndrome in the mouse fetus. Reprod Toxicol 12:139–151
|
| |
| 27. |
Sukra Y, Sastrohadinoto S, Budiarso IT (1976) Effect of selenium and mercury on gross morphology and histopathology of chick
embryos. Poult Sci 55:2424–2433
|
| |
| 28. |
Szabo KT, DiFebbo ME, Phelan DG (1978) The effects of gold-containing compounds on pregnant rabbits and their fetuses. Vet
Pathol 15(Suppl 5):97–102
|
| |
| 29. |
Ferm VH (1971) Developmental malformations induced by cadmium. A study of timed injections during embryogenesis. Biol Neonate
19:101–107
|
| |
| 30. |
Singh J (2003) Gastroschisis is caused by the combination of carbon monoxide and protein–zinc deficiencies in mice. Birth
Defects Res B Dev Reprod Toxicol 68:355–362
|
| |
| 31. |
Pampfer S, Streffer C (1988) Prenatal death and malformations after irradiation of mouse zygotes with neutrons or X-rays.
Teratology 37:599–607
|
| |
| 32. |
Quemelo PR, Lourenco CM, Peres LC (2007) Teratogenic effect of retinoic acid in swiss mice. Acta Cir Bras 22:451–456
|
| |
| 33. |
Haustein KO (1999) Cigarette smoking, nicotine and pregnancy. Int J Clin Pharmacol Ther 37:417–427
|
| |
| 34. |
Haddow JE, Palomaki GE, Holman MS (1993) Young maternal age and smoking during pregnancy as risk factors for gastroschisis.
Teratology 47:225–228
|
| |
| 35. |
Lam PK, Torfs CP (2006) Interaction between maternal smoking and malnutrition in infant risk of gastroschisis. Birth Defects
Res A Clin Mol Teratol 76:182–186
|
| |
| 36. |
Torfs CP, Velie EM, Oechsli FW, Bateson TF, Curry CJ (1994) A population-based study of gastroschisis: demographic, pregnancy,
and lifestyle risk factors. Teratology 50:44–53
|
| |
| 37. |
Yan J, Hales BF (2006) Depletion of glutathione induces 4-hydroxynonenal protein adducts and hydroxyurea teratogenicity in
the organogenesis stage mouse embryo. J Pharmacol Exp Ther 319:613–621
|
| |
| 38. |
Mayura K, Reddy RV, Hayes AW, Berndt WO (1982) Embryocidal, fetotoxic and teratogenic effects of ochratoxin A in rats. Toxicology
25:175–185
|
| |
| 39. |
Patil RD, Dwivedi P, Sharma AK (2006) Critical period and minimum single oral dose of ochratoxin A for inducing developmental
toxicity in pregnant Wistar rats. Reprod Toxicol 22:679–687
|
| |
| 40. |
Nomura T, Isa Y, Kurokawa N, Kanzaki T, Tanaka H, Tada E, Sakamoto Y (1984) Enhancement effects of barbital on the teratogenicity
of aminopyrine. Toxicology 29:281–291
|
| |
| 41. |
Szabo KT, Guerriero FJ, Kang YJ (1978) The effects of gold-containing compounds on pregnant rats and their fetuses. Vet Pathol
Suppl 15:89–96
|
| |
| 42. |
Chaudhury MR, Chandrasekaran R, Mishra S (2001) Embryotoxicity and teratogenicity studies of an ayurvedic contraceptive—pippaliyadi
vati. J Ethnopharmacol 74:189–193
|
| |
| 43. |
Hoffman DJ, Moore JM (1979) Teratogenic effects of external egg applications of methyl mercury in the mallard, Anas platyrhynchos.
Teratology 20:453–461
|
| |
| 44. |
Barrow MV, Willis LS (1972) Ectopia cordis (ectocardia) and gastroschisis induced in rats by maternal administration of the
lathyrogen, beta-aminopropionitrile (BAPN). Am Heart J 83:518–526
|
| |
| 45. |
Burdan F, Szumilo J, Dudka J, Korobowicz A, Klepacz R (2006) Celosomy is associated with prenatal exposure to cyclooxygenase
inhibitors. Pharmacol Res 53:287–292
|
| |
| 46. |
Kasirsky G, Lombardi L (1970) Comparative teratogenic study of various corticoid ophthalmics. Toxicol Appl Pharmacol 16:773–778
|
| |
| 47. |
Thompson JM, Bannigan JG (2007) Omphalocele induction in the chick embryo by administration of cadmium. J Pediatr Surg 42:1703–1709
|
| |
| 48. |
Hales BF, Crosman K, Robaire B (1992) Increased postimplantation loss and malformations among the F2 progeny of male rats
chronically treated with cyclophosphamide. Teratology 45:671–678
|
| |
| 49. |
Ognio E, Lapide M, Ottone M, Mandys V, Peterka M, Parodi B, Viale M (2003) Embryo-lethal and teratogenic effect of the new
platinum compound DPR in pregnant mice. Arch Toxicol 77:584–590
|
| |
| 50. |
Wangikar PB, Dwivedi P, Sinha N (2004) Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1.
I. Maternal toxicity and fetal malformations. Birth Defects Res B Dev Reprod Toxicol 71:343–351
|
| |
| 51. |
Buttar HS, Dupuis I, Khera KS (1978) Dimethadione-induced fetotoxicity in rats. Toxicology 9:155–164
|
| |
| 52. |
Perez-D’Gregorio RE, Miller RK (1988) Teratogenicity of tellurium dioxide: prenatal assessment. Teratology 37:307–316
|
| |
| 53. |
Perez-D’Gregorio RE, Miller RK, Baggs RB (1988) Maternal toxicity and teratogenicity of tellurium dioxide in the Wistar rat:
relationship to pair-feeding. Reprod Toxicol 2:55–61
|
| |
| 54. |
Ferm VH (1964) Teratogenic effects of hyperbaric oxygen. Proc Soc Exp Biol Med 116:975–976
|
| |
| 55. |
Parman T, Wiley MJ, Wells PG (1999) Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
Nat Med 5:582–585
|
| |
| 56. |
Hung CF (1992) Experimentally induced axial dysraphism and anorectal malformation in male rat fetuses by intragastric administration
of ethylenethiourea. J Formos Med Assoc 91:1166–1169
|
| |
| 57. |
Starkey DD, Nelson T, Shepard TH (1970) Teratogenicity of vitamin B6 deficiency: omphalocele, skeletal and neural defects,
and splenic hypoplasia. Science 169:1329–1330
|
| |
| 58. |
http://www.cdc.gov/nchs/icd9.htm
|
| |
| 59. |
Brewer S, Williams T (2004) Finally, a sense of closure? Animal models of human ventral body wall defects. Bioessays 26:1307–1321
|
| |
| 60. |
Brewer S, Williams T (2004) Loss of AP-2alpha impacts multiple aspects of ventral body wall development and closure. Dev Biol
267:399–417
|
| |
| 61. |
Drongowski RA, Smith RK Jr, Coran AG, Klein MD (1991) Contribution of demographic and environmental factors to the etiology
of gastroschisis: a hypothesis. Fetal Diagn Ther 6:14–27
|
| |
| 62. |
Emusu D, Salihu HM, Aliyu ZY, Pierre-Louis BJ, Druschel CM, Kirby RS (2005) Gastroschisis, low maternal age, and fetal morbidity
outcomes. Birth Defects Res A Clin Mol Teratol 73:649–654
|
| |
| 63. |
Werler MM, Mitchell AA, Shapiro S (1992) Demographic, reproductive, medical, and environmental factors in relation to gastroschisis.
Teratology 45:353–360
|
| |
| 64. |
Draper ES, Rankin J, Tonks AM, Abrams KR, Field DJ, Clarke M, Kurinczuk JJ (2008) Recreational drug use: a major risk factor
for gastroschisis? Am J Epidemiol 167:485–491
|
| |
| 65. |
Torfs CP, Katz EA, Bateson TF, Lam PK, Curry CJ (1996) Maternal medications and environmental exposures as risk factors for
gastroschisis. Teratology 54:84–92
|
| |
| 66. |
Werler MM, Sheehan JE, Mitchell AA (2002) Maternal medication use and risks of gastroschisis and small intestinal atresia.
Am J Epidemiol 155:26–31
|
| |
| 67. |
Werler MM, Mitchell AA, Shapiro S (1992) First trimester maternal medication use in relation to gastroschisis. Teratology
45:361–367
|
| |
| 68. |
Martinez-Frias ML, Rodriguez-Pinilla E, Prieto L (1997) Prenatal exposure to salicylates and gastroschisis: a case-control
study. Teratology 56:241–243
|
| |
| 69. |
Lam PK, Torfs CP, Brand RJ (1999) A low pregnancy body mass index is a risk factor for an offspring with gastroschisis. Epidemiology
10:717–721
|
| |
| 70. |
Torfs CP, Lam PK, Schaffer DM, Brand RJ (1998) Association between mothers’ nutrient intake and their offspring’s risk of
gastroschisis. Teratology 58:241–250
|
| |
| 71. |
Hoyme HE, Higginbottom MC, Jones KL (1981) The vascular pathogenesis of gastroschisis: intrauterine interruption of the omphalomesenteric
artery. J Pediatr 98:228–231
|
| |
| 72. |
Hoyme HE, Jones MC, Jones KL (1983) Gastroschisis: abdominal wall disruption secondary to early gestational interruption of
the omphalomesenteric artery. Semin Perinatol 7:294–298
|
| |
| 73. |
Thompson J, Bannigan J (2001) Effects of cadmium on formation of the ventral body wall in chick embryos and their prevention
by zinc pretreatment. Teratology 64:87–97
|
| |
| 74. |
Thompson J, Hipwell E, Loo HV, Bannigan J (2005) Effects of cadmium on cell death and cell proliferation in chick embryos.
Reprod Toxicol 20:539–548
|
| |
| 75. |
Moore M, Thor H, Moore G, Nelson S, Moldeus P, Orrenius S (1985) The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. J Biol Chem 260:13035–13040
|
| |
| 76. |
Blaszkowska J (2002) Developmental abnormalities in chicken embryos after injection proteolysis inhibitors from Ascaris suum. Wiad Parazytol 48:55–64
|
| |
| 77. |
Zhang X, Schrott LM, Sparber SB (1998) Evidence for a serotonin-mediated effect of cocaine causing vasoconstriction and herniated
umbilici in chicken embryos. Pharmacol Biochem Behav 59:585–593
|
| |
| 78. |
McBride WG, Vardy PH, French J (1982) Effects of scopolamine hydrobromide on the development of the chick and rabbit embryo.
Aust J Biol Sci 35:173–178
|
| |
| 79. |
Guram MS, Gill TS, Geber WF (1982) Comparative teratogenicity of chlordiazepoxide, amitriptyline, and a combination of the
two compounds in the fetal hamster. Neurotoxicology 3:83–90
|
| |
| 80. |
Wei X, Sulik KK (1993) Pathogenesis of craniofacial and body wall malformations induced by ochratoxin A in mice. Am J Med
Genet 47:862–871
|
| |
| 81. |
Khera KS (1976) Teratogenicity studies with methotrexate, aminopterin, and acetylsalicylic acid in domestic cats. Teratology
14:21–27
|
| |
| 82. |
Khera KS, Iverson F (1978) Toxicity of ethylenethiourea in pregnant cats. Teratology 18:311–313
|
| |
| 83. |
Manner J, Seidl W, Heinicke F, Hesse H (2003) Teratogenic effects of suramin on the chick embryo. Anat Embryol (Berl) 206:229–237
|
| |
| 84. |
Ferm VH (1969) The synteratogenic effect of lead and cadmium. Experientia 25:56–57
|
| |
| 85. |
Harris SB, Wilson JG, Printz RH (1972) Embryotoxicity of methyl mercuric chloride in golden hamsters. Teratology 6:139–142
|
| |
| 86. |
Casteel SW, Bailey EM, Camp BJ, Bridges CH, Hejtmancik E, Ueckert DN (1989) The developmental toxicity of an isolate from
the plant Solanum dimidiatum (potato-weed) in Syrian golden hamsters. Toxicon 27:757–762
|
| |
| 87. |
Tellone CI, Baldwin JK, Sofia RD (1980) Teratogenic activity in the mouse after oral administration of acetazolamide. Drug
Chem Toxicol 3:83–98
|
| |
| 88. |
Collins MD, Eckhoff C, Weiss R, Resnick E, Nau H, Scott WJ Jr (2006) Differential teratogenesis of all-trans-retinoic acid
administered on gestational day 9.5 to SWV and C57BL/6N mice: emphasis on limb dysmorphology. Birth Defects Res A Clin Mol
Teratol 76:96–106
|
| |
| 89. |
Takeno S, Sumita M, Saito H, Sakai T (1987) Strain differences in susceptibility to the embryotoxic effects of aminopyrine
in mice. Res Commun Chem Pathol Pharmacol 57:409–419
|
| |
| 90. |
Yamamoto M, Takayama YI, Watanabe M, Ito S, Watanabe GI (1981) Immunological effects of antitestis antisera on the development
of mouse fetuses. Teratology 24:53–63
|
| |
| 91. |
Barbieri O, Ognio E, Rossi O, Astigiano S, Rossi L (1986) Embryotoxicity of benzo(a)pyrene and some of its synthetic derivatives
in Swiss mice. Cancer Res 46:94–98
|
| |
| 92. |
Hovland DN Jr, Machado AF, Scott WJ Jr, Collins MD (1999) Differential sensitivity of the SWV and C57BL/6 mouse strains to
the teratogenic action of single administrations of cadmium given throughout the period of anterior neuropore closure. Teratology
60:13–21
|
| |
| 93. |
Shepard TH, Greenaway JC (1977) Teratogenicity of cytochalasin D in the mouse. Teratology 16:131–136
|
| |
| 94. |
Price CJ, Kimmel CA, George JD, Marr MC (1987) The developmental toxicity of diethylene glycol dimethyl ether in mice. Fundam
Appl Toxicol 8:115–126
|
| |
| 95. |
Rogers JM, Carver B, Gray LE Jr, Gray JA, Kavlock RJ (1986) Teratogenic effects of the fungicide dinocap in the mouse. Teratog
Carcinog Mutagen 6:375–381
|
| |
| 96. |
Nemirovsky MS (1970) The induction of congenital abnormalities in mice by means of heterologous anti-mouse placenta serum.
Experientia 26:1138–1139
|
| |
| 97. |
Seller MJ, Perkins KJ (1983) Effect of hydroxyurea on neural tube defects in the curly-tail mouse. J Craniofac Genet Dev Biol
3:11–17
|
| |
| 98. |
Yusa T (1981) Chromosomal and teratogenic effects of oxygen in the mouse. Br J Anaesth 53:505–510
|
| |
| 99. |
Moallem SA, Niapour M (2008) Study of embryotoxicity of Perovskia abrotanoides, an adulterant in folk-medicine, during organogenesis in mice. J Ethnopharmacol 117:108–114
|
| |
| 100. |
Persaud TV, Henderson WM (1969) The teratogenicity of barbital sodium in mice. Arzneimittelforschung 19:1309–1310
|
| |
| 101. |
Blakley PM, Kim JS, Firneisz GD (1989) Effects of preconceptional and gestational exposure to Tordon 202c on fetal growth
and development in CD-1 mice. Teratology 39:547–553
|
| |
| 102. |
Taubeneck MW, Daston GP, Rogers JM, Gershwin ME, Ansari A, Keen CL (1995) Tumor necrosis factor-alpha alters maternal and
embryonic zinc metabolism and is developmentally toxic in mice. J Nutr 125:908–919
|
| |
| 103. |
Muller WU, Streffer C (1990) Lethal and teratogenic effects after exposure to X-rays at various times of early murine gestation.
Teratology 42:643–650
|
| |
| 104. |
Hillebrandt S, Streffer C (2000) Relative biological effectiveness of neutrons: induction of malformations in a mouse strain
with genetic predisposition. Radiat Res 153:595–598
|
| |
| 105. |
Baatout S, Jacquet P, Michaux A, Buset J, Vankerkom J, Derradji H, Yan J, von Suchodoletz H, de Saint-Georges L, Desaintes
C, Mergeay M (2002) Developmental abnormalities induced by X-irradiation in p53 deficient mice. In Vivo 16:215–221
|
| |
| 106. |
Muller WU, Schotten H (1995) Induction of malformations by X-ray exposure of various stages of the oogenesis of mice. Mutat
Res 331:119–125
|
| |
| 107. |
DeSesso JM (1979) Lectin teratogenesis: defects produced by concanavalin A in fetal rabbits. Teratology 19:15–25
|
| |
| 108. |
Cappon GD, Cook JC, Hurtt ME (2003) Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development
when administered to rats and rabbits during the sensitive periods for heart development and midline closure. Birth Defects
Res B Dev Reprod Toxicol 68:47–56
|
| |
| 109. |
Kelich SL, Mercieca MD, Pohland RC (1995) Developmental toxicity of N-methylformamide administered by gavage to CD rats and
New Zealand white rabbits. Fundam Appl Toxicol 27:239–246
|
| |
| 110. |
Rosen MB, House HS, Francis BM, Chernoff N (1990) Teratogenicity of 5-azacytidine in the Sprague–Dawley rat. J Toxicol Environ
Health 29:201–210
|
| |
| 111. |
Kimmel CA, Wilson JG, Schumacher HJ (1971) Studies on metabolism and identification of the causative agent in aspirin teratogenesis
in rats. Teratology 4:15–24
|
| |
| 112. |
Ong LL, Schardein JL, Petrere JA, Sakowski R, Jordan H, Humphrey RR, Fitzgerald JE, de la Iglesia FA (1983) Teratogenesis
of calcium valproate in rats. Fundam Appl Toxicol 3:121–126
|
| |
| 113. |
Sitarek K (2001) Embryolethal and teratogenic effects of carbendazim in rats. Teratog Carcinog Mutagen 21:335–340
|
| |
| 114. |
Kai S, Kohmura H, Ishikawa K, Makihara Y, Ohta S, Kawano S, Takahashi N (1989) Teratogenic effects of carboplatin, an oncostatic
drug, administered during the early organogenetic period in rats. J Toxicol Sci 14:115–130
|
| |
| 115. |
Slott VL, Hales BF (1986) Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in
rats. Toxicol Appl Pharmacol 82:80–86
|
| |
| 116. |
Mosier HD Jr, Dearden LC, Jansons RA, Roberts RC, Biggs CS (1982) Disproportionate growth of organs and body weight following
glucocorticoid treatment of the rat fetus. Dev Pharmacol Ther 4:89–105
|
| |
| 117. |
Ema M, Itami T, Kawasaki H (1992) Susceptible period for the teratogenicity of di-n-butyltin dichloride in rats. Toxicology 73:81–92
|
| |
| 118. |
Neeper-Bradley TL, Tyl RW, Fisher LC, Kubena MF, Vrbanic MA, Losco PE (1995) Determination of a no-observed-effect level for
developmental toxicity of ethylene glycol administered by gavage to CD rats and CD-1 mice. Fundam Appl Toxicol 27:121–130
|
| |
| 119. |
Yoshimura H (1987) Teratogenicity of flubendazole in rats. Toxicology 43:133–138
|
| |
| 120. |
Leung CC, Yan CL, Cheewatrakoolpong B (1990) Autologous immune complex glomerulonephritis induces abnormal embryonic development.
J Reprod Immunol 17:141–154
|
| |
| 121. |
Hackett PL, Hess JO, Sikov MR (1982) Distribution and effects of intravenous lead in the fetoplacental unit of the rat. J
Toxicol Environ Health 9:1021–1032
|
| |
| 122. |
Minsker DH, MacDonald JS, Robertson RT, Bokelman DL (1983) Mevalonate supplementation in pregnant rats suppresses the teratogenicity
of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Teratology 28:449–456
|
| |
| 123. |
Lane GA, Nahrwold ML, Tait AR, Taylor-Busch M, Cohen PJ, Beaudoin AR (1980) Anesthetics as teratogens: nitrous oxide is fetotoxic,
xenon is not. Science 210:899–901
|
| |
| 124. |
Beaudoin AR (1982) Teratogenic action of platinum thymine blue. Life Sci 31:757–762
|
| |
| 125. |
Burdan F (2004) Developmental effects of propyphenazone in analgesic and antipyretic combination with caffeine or paracetamol.
Hum Exp Toxicol 23:235–244
|
| |
| 126. |
Wise LD, Vetter CM, Anderson CA, Antonello JM, Clark RL (1991) Reversible effects of triamcinolone and lack of effects with
aspirin or L-656, 224 on external genitalia of male Sprague–Dawley rats exposed in utero. Teratology 44:507–520
|
| |
| 127. |
Woodard JC (1970) Effects of deficiencies in labile methyl groups on the growth and development of fetal rats. J Nutr 100:1215–1225
|
| |
| 128. |
Woodard JC (1969) Study of one-carbon metabolism in neonatal vitamin B12-deficient rats. J Nutr 98:139–146
|
| |